Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Common Equity (2021 - 2025)

Rxo's Common Equity history spans 5 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Common Equity fell 4.4% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, down 4.4%, while the annual FY2025 figure was $1.5 billion, 4.4% down from the prior year.
  • Common Equity reached $1.5 billion in Q4 2025 per RXO's latest filing, down from $1.6 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.7 billion in Q3 2024 to a low of $579.0 million in Q2 2024.
  • Average Common Equity over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2021.
  • Peak YoY movement for Common Equity: crashed 50.88% in 2023, then soared 180.0% in 2024.
  • A 5-year view of Common Equity shows it stood at $1.1 billion in 2021, then plummeted by 45.14% to $587.0 million in 2022, then increased by 1.19% to $594.0 million in 2023, then skyrocketed by 171.38% to $1.6 billion in 2024, then decreased by 4.4% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for RXO's Common Equity are $1.5 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025).